Cargando…

Association of TM6SF2 rs58542926 gene polymorphism with the risk of non-alcoholic fatty liver disease and colorectal adenoma in Chinese Han population

BACKGROUND: Genetic factors affect the risk of non-alcoholic fatty liver disease (NAFLD) and colorectal adenoma (CRA) importantly. Transmembrane protein 6 superfamily member 2 (TM6SF2) rs58542926 is a significant genetic susceptibility site for NAFLD. The relationships of TM6SF2 rs58542926 with the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Yuan, Liu, Shousheng, Gao, Yuqiang, Ma, Huan, Zhan, Shuhui, Yang, Yan, Xin, Yongning, Xuan, Shiying
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6364404/ https://www.ncbi.nlm.nih.gov/pubmed/30727943 http://dx.doi.org/10.1186/s12858-019-0106-3

Ejemplares similares

Association between NAFLD and Risk of Colorectal Adenoma in Chinese Han Population
por: Li, Yuan, et al.
Publicado: (2019)

TM6SF2 rs58542926 influences hepatic fibrosis progression in patients with non-alcoholic fatty liver disease
por: Liu, Yang-Lin, et al.
Publicado: (2014)

Association of TM6SF2 rs58542926 T/C gene polymorphism with hepatocellular carcinoma: a meta-analysis
por: Tang, Shan, et al.
Publicado: (2019)

Association of PNPLA3 rs738409 and TM6SF2 rs58542926 with health services utilization in a population-based study
por: Köpp, Julia, et al.
Publicado: (2016)

The Genetics of Clinical Liver Diseases: Insight into the TM6SF2 E167K Variant
por: Zhang, Xiaoyu, et al.
Publicado: (2018)

Influence of Type 2 Diabetes in the Association of PNPLA3 rs738409 and TM6SF2 rs58542926 Polymorphisms in NASH Advanced Liver Fibrosis
por: Gabriel-Medina, Pablo, et al.
Publicado: (2022)

TM6SF2 rs58542926 is related to hepatic steatosis, fibrosis and serum lipids both in adults and children: A meta-analysis
por: Li, Xue-Ying, et al.
Publicado: (2022)

TM6SF2-rs58542926 Genetic Variant Modifies the Protective Effect of a “Prudent” Dietary Pattern on Serum Triglyceride Levels
por: Kalafati, Ioanna Panagiota, et al.
Publicado: (2023)

Relationship between AGT rs2493132 polymorphism and the risk of coronary artery disease in patients with NAFLD in the Chinese Han population
por: Dong, Mengzhen, et al.
Publicado: (2021)

Association Between LYPLAL1 rs12137855 Polymorphism With Ultrasound-Defined Non-Alcoholic Fatty Liver Disease in a Chinese Han Population
por: Yuan, Chen, et al.
Publicado: (2015)

Association of GCKR Gene Polymorphisms with the Risk of Nonalcoholic Fatty Liver Disease and Coronary Artery Disease in a Chinese Northern Han Population
por: Gao, Hui, et al.
Publicado: (2019)

Association of PNPLA3 (rs738409) & TM6SF2 (rs58542926) and ATG16L1 (rs2241880) genetic variants with susceptibility to hepatocellular carcinoma in a group of Egyptian patients with HCV-induced liver cirrhosis
por: Mohamed Fteah, Asmaa, et al.
Publicado: (2023)

Association of Nonalcoholic Fatty Liver Disease and Coronary Artery Disease with FADS2 rs3834458 Gene Polymorphism in the Chinese Han Population
por: Xu, Yingyu, et al.
Publicado: (2019)

TM6SF2 E167K Variant Overexpression Promotes Expression of Inflammatory Cytokines in the HCC Cell Line HEPA 1-6
por: Du, Shuixian, et al.
Publicado: (2019)

Association of LDLR rs1433099 with the Risk of NAFLD and CVD in Chinese Han Population
por: Han, Yi, et al.
Publicado: (2021)

E167K polymorphism of TM6SF2 gene affects cell cycle of hepatocellular carcinoma cell HEPA 1-6
por: Du, Shuixian, et al.
Publicado: (2017)

Association of TCF7L2 rs7903146 Gene Polymorphism with the Risk of NAFLD and CAD in the Chinese Han Population
por: Yan, Xin, et al.
Publicado: (2020)

The additive effects of the TM6SF2 E167K and PNPLA3 I148M polymorphisms on lipid metabolism
por: Chen, Lizhen, et al.
Publicado: (2017)

Association between the LRP5 rs556442 gene polymorphism and the risks of NAFLD and CHD in a Chinese Han population
por: Han, Dongli, et al.
Publicado: (2022)

Relationship of circulating total bilirubin, UDP-glucuronosyltransferases 1A1 and the development of non-alcoholic fatty liver disease: a cross-sectional study
por: Ma, Xuefeng, et al.
Publicado: (2022)

Noninvasive Quantitative Detection Methods of Liver Fat Content in Nonalcoholic Fatty Liver Disease
por: Lv, Shujing, et al.
Publicado: (2018)

NOTCH3 rs1043996 Polymorphism Is Associated with the Occurrence of Alcoholic Liver Cirrhosis Independently of PNPLA3 and TM6SF2 Polymorphisms
por: Bainrauch, Ana, et al.
Publicado: (2021)

The association between SNPs rs1800591 and rs3816873 of the MTTP gene and nonalcoholic fatty liver disease: A meta-analysis
por: Tan, Jie, et al.
Publicado: (2020)

The roles of transmembrane 6 superfamily member 2 rs58542926 polymorphism in chronic liver disease: A meta‐analysis of 24,147 subjects
por: Chen, Xinpei, et al.
Publicado: (2019)

TRIB1 rs17321515 and rs2954029 gene polymorphisms increase the risk of non-alcoholic fatty liver disease in Chinese Han population
por: Liu, Qun, et al.
Publicado: (2019)

Association of Tumor Necrosis Factor-alpha Polymorphisms and Risk of Coronary Artery Disease in Patients With Non-alcoholic Fatty Liver Disease
por: Cheng, Yuting, et al.
Publicado: (2015)

Disruption of the ERLIN–TM6SF2–APOB complex destabilizes APOB and contributes to non-alcoholic fatty liver disease
por: Li, Bo-Tao, et al.
Publicado: (2020)

PNPLA3 and TM6SF2 polymorphisms in Brazilian patients with nonalcoholic fatty liver disease
por: Lisboa, Quelson Coelho, et al.
Publicado: (2020)

Genetic Variants in the SAMM50 Gene Create Susceptibility to Nonalcoholic Fatty Liver Disease in a Chinese Han Population
por: Chen, Lizhen, et al.
Publicado: (2015)

Three Members of Transmembrane-4-Superfamily, TM4SF1, TM4SF4, and TM4SF5, as Emerging Anticancer Molecular Targets against Cancer Phenotypes and Chemoresistance
por: Rahim, Nur Syafiqah, et al.
Publicado: (2023)

Down-regulation of TM4SF is associated with the metastatic potential of gastric carcinoma TM4SF members in gastric carcinoma
por: Chen, Zhouxun, et al.
Publicado: (2011)

Apolipoprotein C3 Gene Polymorphisms Are Not a Risk Factor for Developing Non-Alcoholic Fatty Liver Disease: A Meta-Analysis
por: Zhang, Haiying, et al.
Publicado: (2014)

Mechanism and therapeutic strategy of hepatic TM6SF2-deficient non-alcoholic fatty liver diseases via in vivo and in vitro experiments
por: Li, Zu-Yin, et al.
Publicado: (2022)

TM4SF5-mediated abnormal food-intake behavior and apelin expression facilitate non-alcoholic fatty liver disease features
por: Pinanga, Yangie Dwi, et al.
Publicado: (2023)

Serum 25-hydroxyvitamin D levels and the risk of non-alcoholic fatty liver: A two-sample Mendelian randomization study
por: Sheng, Qi, et al.
Publicado: (2022)

TM6SF2: A Novel Genetic Player in Nonalcoholic Fatty Liver and Cardiovascular Disease
por: Luo, Fei, et al.
Publicado: (2021)

Additive Effects of the Risk Alleles of PNPLA3 and TM6SF2 on Non-alcoholic Fatty Liver Disease (NAFLD) in a Chinese Population
por: Wang, Xiaoliang, et al.
Publicado: (2016)

Targeting TM4SF5 with anti-TM4SF5 monoclonal antibody suppresses the growth and motility of human pancreatic cancer cells
por: Park, Sangkyu, et al.
Publicado: (2020)

Myeloid TM6SF2 Deficiency Inhibits Atherosclerosis
por: Zhu, Wenzhen, et al.
Publicado: (2022)

Anti-cancer Activity of Novel TM4SF5-Targeting Antibodies through TM4SF5 Neutralization and Immune Cell-Mediated Cytotoxicity
por: Ahn, Hye-Mi, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_v0ghkiilp2dbnel7io6tjltade